Gelonghui, April 5 | According to the latest equity disclosure data on the Stock Exchange, on March 27, 2024, Pharmaceutical Biotech (02269.HK) obtained JPMorgan Chase & Co. to increase its holding of 3.406 million shares at an average price of HK$13.6846 per share, involving approximately HK$46.61 million.
After the increase in holdings, JPMorgan Chase & Co.'s latest number of open positions was 213,733,454 shares, and the holding ratio increased from 4.93% to 5.01%.
